Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Sell
37
SMG Quote, Financials, Valuation and Earnings
Last price:
$70.22
Seasonality move
:
3.65%
Day range:
$69.74 - $71.79
52-week range:
$53.43 - $93.90
Dividend yield:
3.73%
P/E ratio:
--
P/S ratio:
1.14x
P/B ratio:
--
Volume:
461.3K
Avg. volume:
639K
1-year change:
21.15%
Market cap:
$4.1B
Revenue:
$3.6B
EPS (TTM):
-$0.69
Analysts' Opinion
-
Consensus RatingThe Scotts Miracle Gro has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $79.25, The Scotts Miracle Gro has an estimated upside of 12.74% from its current price of $70.85.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $70.00 representing 1.2% downside risk from its current price of $70.85.
Fair Value
-
According to the consensus of 9 analysts, The Scotts Miracle Gro has 12.74% upside to fair value with a price target of $79.25 per share.
SMG vs. S&P 500
-
Over the past 5 trading days, The Scotts Miracle Gro has overperformed the S&P 500 by 3.34% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
The Scotts Miracle Gro does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Scotts Miracle Gro has grown year-over-year revenues for 2 quarters straight. In the most recent quarter The Scotts Miracle Gro reported revenues of $414.7M.
Earnings Growth
-
The Scotts Miracle Gro has grown year-over-year earnings for 2 quarters straight. In the most recent quarter The Scotts Miracle Gro reported earnings per share of -$4.29.
Enterprise value:
6.2B
EV / Invested capital:
--
Price / LTM sales:
1.14x
EV / EBIT:
46.01x
EV / Revenue:
1.75x
PEG ratio (5yr expected):
-0.16x
EV / Free cash flow:
10.67x
Price / Operating cash flow:
6.96x
Enterprise value / EBITDA:
28.84x
Gross Profit (TTM):
$850.5M
Return On Assets:
-1%
Net Income Margin (TTM):
-0.98%
Return On Equity:
--
Return On Invested Capital:
-1.49%
Operating Margin:
-35.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $3.9B | $3.6B | $3.6B | $374.5M | $414.7M | |
| Gross Profit | $872.9M | $657.3M | $850.5M | -$57M | -$29.5M | |
| Operating Income | $257.5M | $106.1M | $271.7M | -$167.6M | -$147.4M | |
| EBITDA | -$334.7M | -$182.5M | $215.9M | -$498.5M | -$259M | |
| Diluted EPS | -$7.94 | -$6.79 | -$0.69 | -$8.33 | -$4.29 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $2B | $2B | $1.4B | $980.4M | |
| Total Assets | $3.4B | $4.8B | $4.3B | $3.4B | $2.9B | |
| Current Liabilities | $950.4M | $1.1B | $963.9M | $773.7M | $750.3M | |
| Total Liabilities | $2.7B | $3.8B | $4.1B | $3.7B | $3.3B | |
| Total Equity | $702.9M | $1B | $147.7M | -$267.3M | -$390.6M | |
| Total Debt | $1.5B | $2.3B | $3B | $2.6B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$129M | $531M | $667.5M | $535.3M | $118.5M | |
| Cash From Investing | -$283.2M | -$65.7M | -$100.4M | -$21.1M | -$20.4M | |
| Cash From Financing | $255.3M | -$520.1M | -$527.9M | -$509.1M | -$306.8M | |
| Free Cash Flow | -$242.5M | $438.2M | $583.5M | $516.3M | $101.9M | |
SMG
Sector
Market Cap
$4.1B
$18.7M
Price % of 52-Week High
75.45%
60.22%
Dividend Yield
3.73%
0%
Shareholder Yield
6.59%
1.57%
1-Year Price Total Return
21.15%
-14.61%
Beta (5-Year)
1.728
1.044
Dividend yield:
3.73%
Annualized payout:
$2.64
Payout ratio:
-433.52%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$68.31
200-day SMA
Sell
Level
$72.27
Bollinger Bands (100)
Sell
Level
68.36 - 84.06
Chaikin Money Flow
Buy
Level
61M
20-day SMA
Buy
Level
$67.71
Relative Strength Index (RSI14)
Buy
Level
53.62
ADX Line
Buy
Level
30.33
Williams %R
Sell
Level
-12.9298
50-day SMA
Sell
Level
$72.89
MACD (12, 26)
Sell
Level
-1.17
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
64.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.5471)
Sell
CA Score
(Annual)
Level (-2.6033)
Buy
Beneish M-Score
(Annual)
Level (-4.0775)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (9.1623)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the us. The business consists of three reporting segments: us consumer, Hawthorne, and other. The us consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. us consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the us, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.
Stock Forecast FAQ
In the current month, SMG has received 3 Buy ratings 6 Hold ratings, and 0 Sell ratings. The SMG average analyst price target in the past 3 months is $79.25.
-
Where Will The Scotts Miracle Gro Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Scotts Miracle Gro share price will rise to $79.25 per share over the next 12 months.
-
What Do Analysts Say About The Scotts Miracle Gro?
Analysts are divided on their view about The Scotts Miracle Gro share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Scotts Miracle Gro is a Sell and believe this share price will drop from its current level to $70.00.
-
What Is The Scotts Miracle Gro's Price Target?
The price target for The Scotts Miracle Gro over the next 1-year time period is forecast to be $79.25 according to 9 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is SMG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Scotts Miracle Gro is a Hold. 6 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SMG?
You can purchase shares of The Scotts Miracle Gro via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Scotts Miracle Gro shares.
-
What Is The The Scotts Miracle Gro Share Price Today?
The Scotts Miracle Gro was last trading at $70.22 per share. This represents the most recent stock quote for The Scotts Miracle Gro. Yesterday, The Scotts Miracle Gro closed at $70.85 per share.
-
How To Buy The Scotts Miracle Gro Stock Online?
In order to purchase The Scotts Miracle Gro stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
Sell
34
NGVT alert for Jan 17
Ingevity [NGVT] is up 1.31% over the past day.
